îæ€çŽ¢
îæ€çŽ¢
î
China SXT Pharmaceuticals Inc
SXTCîãŠã©ãããªã¹ãã«è¿œå
1.580USD
-0.020-1.25%
çµå€Â 05/15, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
10.20Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± China SXT Pharmaceuticals Inc äŒæ¥å
China SXT Pharmaceuticals Inc is a holding company principally engaged in the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). TCMP is a type of Chinese Traditional Medicine (TCM) products. The Company sells three types of TCMP products: Advanced TCMP, Fine TCMP and Regular TCMP. The Company sells its products under the brand Suxuantang. The Company mainly operates its businesses in the domestic market.
China SXT Pharmaceuticals Incã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãSXTC
äŒç€ŸåChina SXT Pharmaceuticals Inc
äžå Žæ¥Jan 04, 2019
æé«çµå¶è²¬ä»»è
ãCEOãBeng (Lim Sze)
åŸæ¥å¡æ°75
蚌åžçš®é¡Ordinary Share
決ç®ææ«Jan 04
æ¬ç€Ÿæåšå°178 Taidong Road North
éœåžTAIZHOU
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœChina
éµäŸ¿çªå·225300
é»è©±çªå·8652386298290
ãŠã§ããµã€ãhttps://www.sxtchina.com/
äŒæ¥ã³ãŒãSXTC
äžå Žæ¥Jan 04, 2019
æé«çµå¶è²¬ä»»è
ãCEOãBeng (Lim Sze)
China SXT Pharmaceuticals Incã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
4.00
-1425.00%
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
Mr. Lip Chee Yong
Mr. Lip Chee Yong
Independent Director
Independent Director
--
--
Mr. Lim Sze (Simon) Beng
Mr. Lim Sze (Simon) Beng
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
4.00
-1425.00%
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
Mr. Lip Chee Yong
Mr. Lip Chee Yong
Independent Director
Independent Director
--
--
åçå èš³
é貚: USDæŽæ°æå»: Mon, Apr 6
é貚: USDæŽæ°æå»: Mon, Apr 6
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
äºæ¥å¥USD
äŒç€Ÿå
åç
æ¯ç
Regular TCMP
1.44M
82.86%
Advanced TCMP
258.42K
14.84%
Others
40.02K
2.30%
å°åå¥USD
äŒç€Ÿå
åç
æ¯ç
People's Republic of China
1.74M
100.00%
äºæ¥å¥
å°åå¥
äºæ¥å¥USD
äŒç€Ÿå
åç
æ¯ç
Regular TCMP
1.44M
82.86%
Advanced TCMP
258.42K
14.84%
Others
40.02K
2.30%
æ ªäž»
æŽæ°æå»: Thu, Feb 19
æŽæ°æå»: Thu, Feb 19
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Foong Soon Hong (Randy)
1.09%
Seng (Tan Soo)
1.07%
Tan (Cheng Guan)
1.05%
Ching (Choon Hwa)
1.01%
Citadel Advisors LLC
0.02%
ä»ã®
95.75%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Foong Soon Hong (Randy)
1.09%
Seng (Tan Soo)
1.07%
Tan (Cheng Guan)
1.05%
Ching (Choon Hwa)
1.01%
Citadel Advisors LLC
0.02%
ä»ã®
95.75%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Individual Investor
4.23%
Hedge Fund
0.02%
ä»ã®
95.75%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
18
2.18K
0.03%
+69.00
2025Q4
18
2.07K
0.22%
+1.90K
2025Q3
18
220.19K
0.19%
+206.13K
2025Q2
20
28.22K
2.38%
-47.81K
2025Q1
20
28.22K
0.02%
-47.80K
2024Q4
22
74.93K
15.02%
+42.94K
2024Q3
24
33.98K
13.64%
+10.51K
2024Q2
21
35.50K
15.27%
+22.93K
2024Q1
24
15.92K
23.88%
+2.99K
2023Q4
23
15.02K
23.00%
+2.57K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Foong Soon Hong (Randy)
70.59K
7.37%
+70.59K
--
Jul 29, 2025
Seng (Tan Soo)
69.28K
7.24%
+69.28K
--
Jul 29, 2025
Tan (Cheng Guan)
67.97K
7.1%
+67.97K
--
Jul 29, 2025
Ching (Choon Hwa)
65.36K
6.83%
+65.36K
--
Jul 29, 2025
Citadel Advisors LLC
1.00K
0.1%
+679.00
+208.92%
Dec 31, 2025
Geode Capital Management, L.L.C.
358.00
0.04%
--
--
Dec 31, 2025
XTX Markets LLC
152.00
0.02%
+152.00
--
Dec 31, 2025
Virtu Americas LLC
82.00
0.01%
-111.00
-57.51%
Dec 31, 2025
Forsakringsaktiebolaget Skadinviska Enskilda
38.00
0%
+12.00
+46.15%
Aug 07, 2024
Tower Research Capital LLC
12.00
0%
-7.00
-36.84%
Dec 31, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
Invesco Golden Dragon China ETF
0.08%
Invesco Golden Dragon China ETF
æ¯ç0.08%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
Jan 30, 2026
Merger
150â1
Feb 21, 2025
Merger
8â1
Feb 21, 2025
Merger
8â1
Feb 21, 2025
Merger
8â1
Feb 21, 2025
Merger
8â1
Oct 04, 2023
Merger
25â1
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
Jan 30, 2026
Merger
150â1
Feb 21, 2025
Merger
8â1
Feb 21, 2025
Merger
8â1
Feb 21, 2025
Merger
8â1
Feb 21, 2025
Merger
8â1
Oct 04, 2023
Merger
25â1
Oct 04, 2023
Merger
25â1
Oct 04, 2023
Merger
25â1
Oct 04, 2023
Merger
25â1
May 18, 2022
Merger
20â1
詳现ãèŠã
